{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26151135", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "21"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "07", "Day": "07"}], "ELocationID": ["e0131165", "10.1371/journal.pone.0131165"], "Language": ["eng"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "7", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Pharmacokinetics of Active Components of Yokukansan, a Traditional Japanese Herbal Medicine after a Single Oral Administration to Healthy Japanese Volunteers: A Cross-Over, Randomized Study.", "Pagination": {"StartPage": "e0131165", "MedlinePgn": "e0131165"}, "Abstract": {"AbstractText": ["Yokukansan (YKS) is a traditional Japanese herbal medicine called kampo medicine in Japan. Its extract comprises seven crude drugs: Atractylodis lanceae rhizoma, Poria, Cnidii rhizoma, Uncariae uncis cum ramulus, Angelicae radix, Bupleuri radix, and Glycyrrhizae radix. YKS is used to treat neurosis, insomnia, as well as behavioral and psychological symptoms of dementia.", "To confirm the exposure and pharmacokinetics of the active components of YKS in healthy volunteers.", "A randomized, open-label, 3-arm, 3-period, crossover trial was conducted on 21 healthy Japanese volunteers at the Kochi Medical University between May 2012 and November 2012.", "Single oral administration of YKS (2.5 g, 5.0 g, or 7.5 g/day) during each period.", "Plasma concentrations of three active compounds in YKS, namely 18\u03b2-glycyrrhetinic acid (GA), geissoschizine methyl ether (GM), and hirsuteine (HTE).", "The mean maximum plasma concentrations (Cmax) of GM and HTE increased dose-dependently (ranges: 0.650-1.98 ng/mL and 0.138-0.450 ng/mL, respectively). The times to maximum plasma concentration after drug administration (tmax) were 0.500 h for GM and 0.975-1.00 h for HTE. The apparent elimination half-lives (t1/2) were 1.72-1.95 h for GM and 2.47-3.03 h for HTE. These data indicate the rapid absorption and elimination of GM and HTE. On the other hand, the Cmax, tmax, and t1/2 of GA were 57.7-108 ng/mL, 8.00-8.01 h, and 9.39-12.3 h, respectively.", "We demonstrated that pharmacologically active components of YKS are detected in humans. Further, we determined the pharmacokinetics of GM, HTE, and GA. This information will be useful to elucidate the pharmacological effects of YKS.", "Japan Pharmaceutical Information Center JAPIC CTI-121811."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan."}], "LastName": "Kitagawa", "ForeName": "Hiroyuki", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan."}], "LastName": "Munekage", "ForeName": "Masaya", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical Oncology, Gifu University School of Medicine, Gifu, Japan."}], "LastName": "Ichikawa", "ForeName": "Kengo", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan."}], "LastName": "Fukudome", "ForeName": "Ian", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan."}], "LastName": "Munekage", "ForeName": "Eri", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan."}], "LastName": "Takezaki", "ForeName": "Yuka", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Ibaraki, Japan."}], "LastName": "Matsumoto", "ForeName": "Takashi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kampo Formulations Development Center, Kampo Scientific Strategies Division, Tsumura & Co., Ibaraki, Japan."}], "LastName": "Igarashi", "ForeName": "Yasushi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Elderly General Medicine, Tokyo Medical University, Tokyo, Japan."}], "LastName": "Hanyu", "ForeName": "Haruo", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan."}], "LastName": "Hanazaki", "ForeName": "Kazuhiro", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Indole Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Yi-Gan San"}, {"RegistryNumber": "0", "NameOfSubstance": "geissoschizine methylether"}, {"RegistryNumber": "1449-05-4", "NameOfSubstance": "18alpha-glycyrrhetinic acid"}, {"RegistryNumber": "18904-54-6", "NameOfSubstance": "hirsuteine"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Area Under Curve"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["administration & dosage", "chemistry", "pharmacokinetics"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["analogs & derivatives", "blood"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": [], "DescriptorName": "Healthy Volunteers"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Indole Alkaloids"}, {"QualifierName": [], "DescriptorName": "Japan"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Medicine, Kampo"}, {"QualifierName": [], "DescriptorName": "Metabolic Clearance Rate"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "<b>Competing Interests: </b>This study received grant support from Tsumura & Co. TM and YI are employed by Tsumura & Co., and KH was funded by Tsumura & Co. HK, MM, KI, IF, EM, YT, and HH have no conflicts of interest to declare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mizukami K, Asada T, Kinoshita T, Tanaka K, Sonohara K, Nakai R, et al. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol. 2009; 12: 191\u20139. 10.1017/S146114570800970X .", "ArticleIdList": ["10.1017/S146114570800970X", "19079814"]}, {"Citation": "Matsuda Y, Kishi T, Shibayama H, Iwata N. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol. 2013; 28: 80\u20136. 10.1002/hup.2286 .", "ArticleIdList": ["10.1002/hup.2286", "23359469"]}, {"Citation": "Iwasaki K, Kosaka K, Mori H, Okitsu R, Furukawa K, Manabe Y, et al. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine. Psychogeriatrics. 2012; 12: 235\u201341. 10.1111/j.1479-8301.2012.00413.x .", "ArticleIdList": ["10.1111/j.1479-8301.2012.00413.x", "23279145"]}, {"Citation": "Takeda A, Tamano H, Itoh H, Oku N. Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan. Neurochem Int. 2008; 53: 230\u20135. 10.1016/j.neuint.2008.07.009 .", "ArticleIdList": ["10.1016/j.neuint.2008.07.009", "18755231"]}, {"Citation": "Kawakami Z, Kanno H, Ueki T, Terawaki K, Tabuchi M, Ikarashi Y, et al. Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience. 2009; 159: 1397\u2013407. 10.1016/j.neuroscience.2009.02.004 .", "ArticleIdList": ["10.1016/j.neuroscience.2009.02.004", "19409210"]}, {"Citation": "Kawakami Z, Ikarashi Y, Kase Y. Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes. Eur J Pharmacol. 2010; 626: 154\u20138. 10.1016/j.ejphar.2009.09.046 .", "ArticleIdList": ["10.1016/j.ejphar.2009.09.046", "19818347"]}, {"Citation": "Terawaki K, Ikarashi Y, Sekiguchi K, Nakai Y, Kase Y. Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells. J Ethnopharmacol. 2010; 127: 306\u201312. 10.1016/j.jep.2009.11.003 .", "ArticleIdList": ["10.1016/j.jep.2009.11.003", "19913081"]}, {"Citation": "Nishi A, Yamaguchi T, Sekiguchi K, Imamura S, Tabuchi M, Kanno H, et al. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin (1)A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience. 2012; 207: 124\u201336. 10.1016/j.neuroscience.2012.01.037 .", "ArticleIdList": ["10.1016/j.neuroscience.2012.01.037", "22314317"]}, {"Citation": "Egashira N, Iwasaki K, Ishibashi A, Hayakawa K, Okuno R, Abe M, et al. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1516\u201320. 10.1016/j.pnpbp.2008.05.010 .", "ArticleIdList": ["10.1016/j.pnpbp.2008.05.010", "18558456"]}, {"Citation": "Imamura S, Tabuchi M, Kushida H, Nishi A, Kanno H, Yamaguchi T, et al. The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol. 2011; 31: 787\u201393. 10.1007/s10571-011-9676-3 .", "ArticleIdList": ["10.1007/s10571-011-9676-3", "21442303"]}, {"Citation": "Tabuchi M, Imamura S, Kawakami Z, Ikarashi Y, Kase Y. The blood-brain barrier permeability of 18beta-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol. 2012; 32: 1139\u201346. 10.1007/s10571-012-9839-x .", "ArticleIdList": ["10.1007/s10571-012-9839-x", "22488528"]}, {"Citation": "Kushida H, Fukutake M, Tabuchi M, Katsuhara T, Nishimura H, Ikarashi Y, et al. Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed Chromatogr. 2013; 27: 1647\u201356. 10.1002/bmc.2974 .", "ArticleIdList": ["10.1002/bmc.2974", "23813572"]}, {"Citation": "Hattori M, Sakamoto T, Kobashi K, Namba T. Metabolism of glycyrrhizin by human intestinal flora. Planta Med. 1983; 48: 38\u201342. .", "ArticleIdList": ["6611743"]}, {"Citation": "Xu CH, Wang P, Wang Y, Yang Y, Li DH, Li HF, et al. Pharmacokinetic comparisons of two different combinations of Shaoyao-Gancao Decoction in rats: competing mechanisms between paeoniflorin and glycyrrhetinic acid. J Ethnopharmacol. 2013; 149: 443\u201352. 10.1016/j.jep.2013.06.049 .", "ArticleIdList": ["10.1016/j.jep.2013.06.049", "23867078"]}, {"Citation": "Gough K, Hutchison M, Keene O, Byrom B, Ellis S, Lacey L, et al. Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party. Drug Information Journal. 1995; 29: 1039\u201348. 10.1177/009286159502900324", "ArticleIdList": ["10.1177/009286159502900324"]}, {"Citation": "Smith BP, Vandenhende FR, DeSante KA, Farid NA, Welch PA, Callaghan JT, et al. Confidence interval criteria for assessment of dose proportionality. Pharm Res. 2000; 17: 1278\u201383. .", "ArticleIdList": ["11145235"]}, {"Citation": "Nakazawa T, Banba K, Hata K, Nihei Y, Hoshikawa A, Ohsawa K. Metabolites of hirsuteine and hirsutine, the major indole alkaloids of Uncaria rhynchophylla, in rats. Biol Pharm Bull. 2006; 29: 1671\u20137. JST.JSTAGE/bpb/29.1671 [pii] .", "ArticleIdList": ["16880624"]}, {"Citation": "Goldstein JA, de Morais SM. Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics. 1994; 4: 285\u201399. .", "ArticleIdList": ["7704034"]}, {"Citation": "Terasawa K, Bandoh M, Tosa H, Hirate J. Disposition of glycyrrhetic acid and its glycosides in healthy subjects and patients with pseudoaldosteronism. J Pharmacobiodyn. 1986; 9: 95\u2013100. .", "ArticleIdList": ["3519921"]}, {"Citation": "Takeda S, Ishthara K, Wakui Y, Amagaya S, Maruno M, Akao T, et al. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis. J Pharm Pharmacol. 1996; 48: 902\u20135. .", "ArticleIdList": ["8910850"]}, {"Citation": "Mizuhara Y, Takizawa Y, Ishihara K, Asano T, Kushida H, Morota T, et al. The influence of the sennosides on absorption of glycyrrhetic acid in rats. Biol Pharm Bull. 2005; 28: 1897\u2013902. JST.JSTAGE/bpb/28.1897 [pii] .", "ArticleIdList": ["16204942"]}, {"Citation": "Cantelli-Forti G, Maffei F, Hrelia P, Bugamelli F, Bernardi M, D'Intino P, et al. Interaction of licorice on glycyrrhizin pharmacokinetics. Environ Health Perspect. 1994; 102 Suppl 9: 65\u20138. ; PMCID: PMC1566785.", "ArticleIdList": ["PMC1566785", "7698088"]}, {"Citation": "Krahenbuhl S, Hasler F, Krapf R. Analysis and pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in humans and experimental animals. Steroids. 1994; 59: 121\u20136. 0039-128X(94)90088-4 [pii] .", "ArticleIdList": ["8191540"]}, {"Citation": "Raggi MA, Bugamelli F, Nobile L, Schiavone P, Cantelli-Forti G. HPLC determination of glycyrrhizin and glycyrrhetic acid in biological fluids, after licorice extract administration to humans and rats. Boll Chim Farm. 1994; 133: 704\u20138. .", "ArticleIdList": ["7654308"]}, {"Citation": "Hou YC, Hsiu SL, Ching H, Lin YT, Tsai SY, Wen KC, et al. Profound difference of metabolic pharmacokinetics between pure glycyrrhizin and glycyrrhizin in licorice decoction. Life Sci. 2005; 76: 1167\u201376. S0024-3205(04)00938-5 .", "ArticleIdList": ["15620580"]}, {"Citation": "Miyamura M, Ono M, Kyotani S, Nishioka Y. [Properties of glycyrrhizin in Kampo extracts including licorice root and changes in the blood concentration of glycyrrhetic acid after oral administration of Kampo extracts]. Yakugaku Zasshi. 1996; 116: 209\u201316. .", "ArticleIdList": ["8721349"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "10", "Day": "30"}, {"Year": "2015", "Month": "5", "Day": "28"}, {"Year": "2015", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "7", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["26151135", "PMC4495062", "10.1371/journal.pone.0131165", "PONE-D-14-31608"]}}], "PubmedBookArticle": []}